A federal rule change could moot interstate battles over mifepristone
Overview When the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization (2022) 597 U.S. 215 reverted many questions about abortion rights back to the states, it set the stage for an interstate battle over telemedicine services that cross state lines. The opening moves in that battle are already playing out, and it is too early to predict who will prevail in that fight. But it may all soon be moot if the Federal Drug Administration restricts the current availability of mifepristone though telehealth. Several state attorneys general are currently urging the FDA to do so — a move...
